There is an opportunity for CPH2 to potentially become one of most competitive electrolysis technologies in the world

Clean Power Hydrogen Group (CPH2) is the developer of proprietary technologies addressing the hydrogen economy, forecast to be worth $2.5trillion globally by 2050.

The Company’s patented technology is designed to produce hydrogen and pure oxygen from water in a simple, safe and sustainable way and at scale. CPH2 has advanced the development of hydrogen as a green energy by demonstrating a new form of production.

The technology includes a Membrane-Free Electrolyser™ (MFE) in combination with cryogenic separation to deliver pure hydrogen and pure oxygen as separate gases. The system is simple, safe and sustainable, made of non-exotic materials, providing a cost-effective alternative to both alkaline and PEM electrolysis.  The technology may be deployed at any scale and into a wide variety of applications. When supplied by renewable electricity, the technology delivers green hydrogen.

The Directors believe that the Company’s technology is more efficient than industry competitors and as such, has the ability to meaningfully contribute towards the reduction of carbon dioxide emissions and improve the health and well-being of populations by reducing air pollution and particulate emissions.

Clean Power Hydrogen plc (CPH2), has raised £30 million in an Initial Public Offering, with the Company’s shares admitted to trading on AIM on 16 February, valuing the Company at £119.4 million. Backers in the IPO include strategic investor Kenera Energy Solutions (part of KCA Deutag the leading drilling, engineering, and technology company) and a fund linked to one of CPH2’s key customers.

The Company’s nominated adviser and broker is Cenkos Securities. The IPO valuation represents a multiple of 22.5x (before tax relief) for West Hill SEIS/EIS investors in 2017, 9.0x for EIS investors in 2019 and 3.0x for EIS investors in 2020. West Hill investors, including members of the West Hill team, collectively invested £10.4 million in the IPO round.